Short-term reproducibility of a commercial interferon gamma release assay. - Wikidata - wikimedia - TriplyDB

Short-term reproducibility of a commercial interferon gamma release assay.

Short-term reproducibility of a commercial interferon gamma release assay.

http://www.wikidata.org/entity/Q43071927

about

Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare Workers Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.Assessment of Imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Serial testing with an interferon-γ release assay in German healthcare workers.Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.The MIT D-lab electricity-free PortaTherm™ incubator for remote testing with the QuantiFERON®-TB Gold In-Tube assay.Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection.Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics Consistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum.Outbreak of transient conversions of the QuantiFERON-TB Gold In-Tube test in laboratory health care worker screenings Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review.Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification Effects of acute critical illnesses on the performance of interferon-gamma release assay Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients.Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection.The role of interferon-gamma release assay in tuberculosis control.Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease.

P2860

Q21296671-AF1DD8A4-D2B9-4FB7-BC44-0CC3DD05855D Q28077178-19885198-C080-493C-B559-76C87C9017C0 Q28478603-4F71C64B-5F19-47F5-98BD-E869D8F8FDC4 Q33521202-18B7BE14-7355-4B4D-ACF3-872680E72E0D Q33599396-9ECC08EB-87A8-4F16-BE42-C91BA2702E34 Q33638976-EACE50EA-35A5-4212-A462-4D649AFF87E3 Q33768656-0881D0EE-3FF5-4783-968E-431052CDA5E4 Q33792760-D2A3FE38-BF78-4A30-B3E7-EC2FE4500716 Q34180929-739E2816-DC17-430E-8768-2C1FB94A9804 Q34412119-7541B2EA-E5DE-4CF5-B780-AE081B6AD38C Q34450737-B715F0D3-46C6-4C1C-9274-085D19D263E9 Q34731357-5D25483F-4508-44AC-81FF-AE44A9BA58E0 Q35036937-6A184250-E4BB-4170-9712-18349DA580AF Q35138614-D703E7DA-1432-47DB-8847-57B739ECE268 Q35139729-8486CB3C-59ED-4CD3-A953-E3622EF91113 Q35783572-29542D7B-156A-459D-A67D-A9F64ADA99C1 Q35852451-331E40E4-C7AA-4D56-96A6-818D1E81804E Q36017743-7B2F74F4-A6A3-4B0E-8556-74BE6603E4FD Q36040080-E9213F36-217A-43FC-B562-B7F6B979BEE5 Q36128602-7D88E652-9663-40F0-808B-2DE0B3AAD67F Q36501008-45BC3947-0B3E-4009-B6CD-820A45957B00 Q36559037-84FB528A-B0CD-4A66-8CE6-254AA52D1128 Q36605086-D3434CE6-1737-4334-9046-F844A1926276 Q36637982-B19FF2CA-469B-480B-AF65-44B72928D9D0 Q37124786-46A8F5DE-C9D3-4224-9684-862F5E011B92 Q37510309-24CC16CD-4A3F-46CA-8D12-4B6B73B44B23 Q37860816-38073AA6-87DE-46CC-951F-086FCCD9CCE5 Q37997253-DC2B5EE8-E927-4299-8CF8-D19AE200E6E0 Q38404818-F053B20D-5EF8-43C5-B7DC-E5CC52E8FC5B Q38664922-0D87CC36-0C0D-406F-985F-6305F52289A2 Q43805075-C69E75F8-F533-4F7D-8D52-D3D136A4CE54 Q47554066-044DD44E-BC37-488A-8B84-6E12AEB6E895 Q51771302-3BFC8BE6-C68F-40CA-AF7B-03A279DF729A

P2860

Short-term reproducibility of a commercial interferon gamma release assay.

http://www.wikidata.org/entity/Q43071927

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Short-term reproducibility of a commercial interferon gamma release assay.

@en

Short-term reproducibility of a commercial interferon gamma release assay.

@nl

type

label

Short-term reproducibility of a commercial interferon gamma release assay.

@en

Short-term reproducibility of a commercial interferon gamma release assay.

@nl

prefLabel

Short-term reproducibility of a commercial interferon gamma release assay.

@en

Short-term reproducibility of a commercial interferon gamma release assay.

@nl

P1433

Q43071927-9069FEED-9241-41B2-9DA8-D1D357316A62

P1476

Q43071927-0884B001-FF01-4809-A1D4-08EA73789EF1

P2093

Q43071927-4A3A0CF7-9323-4C55-9FC0-6BC7B42AA62A

Q43071927-5D6495A2-9147-4E01-B01D-A46417872EF2

Q43071927-5E0A618D-DBF5-4C9E-BE10-D1EBD0896E61

Q43071927-7709917F-F798-40FC-AA84-A64E7E928DF4

Q43071927-84ED8571-5353-4B95-A409-0DA7C4BCE1D8

Q43071927-CA6C8FAC-E93F-4F2F-911F-FC96DAE2EB8A

Q43071927-D89DA9E7-2C97-436B-BA40-547A39132DC2

Q43071927-E94A5A58-621E-47EC-8B5D-33630C6CFA32

Q43071927-FC5B4F24-BA91-4BDA-B8C5-795C4E0226EC

P2860

Q43071927-11201431-9563-46BE-B352-758E9B2C2745

Q43071927-1E77AE16-4D07-4854-A400-8BB4DEDFAC93

Q43071927-230EFA0D-26DA-4C1F-BBF2-81B1796774ED

Q43071927-3970D502-B31E-4CD1-95A5-C1BB7FCD35EF

Q43071927-3F19AD62-6948-402D-AC0C-0002CE37AF9E

Q43071927-411576C8-4C92-48AB-A8C0-67CA4526C609

Q43071927-4B5A7B6F-5D61-40C1-AD9D-C077CFF05D0B

Q43071927-6774090F-EBA8-4C53-84B3-1266FC0044D3

Q43071927-87BE4C71-8453-4C8A-98BA-AA902D4A13D4

Q43071927-8DDBF741-ECF2-40C2-948C-DC26E4422F44

P304

Q43071927-C41A3DF1-F7C1-431C-9CAD-C1AD93A2352A

P31

Q43071927-D10C3D60-D7F1-4927-95DF-BCB438451F80

P356

Q43071927-B0FF33C0-00C3-40F1-920E-17FCD9621268

P433

Q43071927-F95D96B6-4EE6-416A-9338-40852F9FB9E4

P478

Q43071927-23612DD7-E481-4BDC-8DBB-0F5868FDE9DB

P50

Q43071927-B19A7798-AB0E-4DAD-ADF1-1F0D3AEE4048

Q43071927-FA1C302B-899D-4032-8201-321E6C635FC8

P577

Q43071927-BE5D7C2F-7AED-4761-B015-FE338E1D1ED6

P698

Q43071927-82A60F2C-3234-4661-BFEC-E29FBEC4F0CC

P921

Q43071927-1ECDAEEC-8759-4969-8E22-1994460DFE0A

P932

Q43071927-CDE83812-0EE4-4593-8ED5-2892E0088826

P356

P1433

Clinical and Vaccine Immunology

P1476

Short-term reproducibility of a commercial interferon gamma release assay

@en

P2093

A C Hesseling

http://www.w3.org/2001/XMLSchema#string

A Gutschmidt

http://www.w3.org/2001/XMLSchema#string

A K Detjen

http://www.w3.org/2001/XMLSchema#string

C Kruger

http://www.w3.org/2001/XMLSchema#string

H M S Grewal

http://www.w3.org/2001/XMLSchema#string

K Stanley

http://www.w3.org/2001/XMLSchema#string

L Loebenberg

http://www.w3.org/2001/XMLSchema#string

M Kidd

http://www.w3.org/2001/XMLSchema#string

N Beyers

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases.

Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.

Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression.

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.

Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Reproducibility of QuantiFERON-TB gold in-tube assay.

Serial testing of health care workers for tuberculosis using interferon-gamma assay.

P304

1170-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00168-09

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Nelita Du Plessis

P577

2009-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19535542

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

P932

2725540

http://www.w3.org/2001/XMLSchema#string